Oncology Practice Management Issues


May 2014, Vol 4, No 3

Facing New Vulnerabilities

From the Editor

Challenges come from all directions, and good oncology managers have eyes in the backs of their heads. Two significant challenges arose recently, stemming from a common computer operating system platform as well as from the US government. In April 2014, [ Read More ]

FDA Update

FDA News

Zykadia Approved for Metastatic, ALK-Positive Lung Cancer On April 29, 2014, the US Food and Drug Administration (FDA) approved ceritinib (Zykadia; Novartis) for the treatment of patients with metastatic, anaplastic lymphoma kinase (ALK)-positive non–small-cell lung cancer (NSCLC). Ceritinib is an [ Read More ]

What Constitutes Good Oncology Care?

Quality Care

Quite often I am asked what constitutes “good” oncology care. Many people have their opinions; patients, doctors, allied medical professionals, and even health plan administrators like to weigh in on this issue. Those in the industry often use buzzwords—eg, quality, [ Read More ]

New Clinical Trials Under Way

Clinical Trials Tracker

The following clinical trials are currently recruiting patients with colorectal cancer for inclusion in several investigations. Each trial description includes the NLM Identifier to use as reference with Clinical Trials.gov. 1. Adjuvant Aflibercept for Meta­static Colorectal Cancer This phase 2, [ Read More ]